| 出版应用/物种/样本/稀释 | 参考文献 |
|---|
| Gupta A, Mandal K, Singh P, Sarkar R, Majumdar S. Declining levels of miR-382-3p at puberty trigger the onset of spermatogenesis. Mol Ther Nucleic Acids. 2021;26:192-207 pubmed 出版商 |
| Youssef S, El Khateeb E, Aly D, Moussa M. Striae distensae: Immunohistochemical assessment of hormone receptors in multigravida and nulligravida. J Cosmet Dermatol. 2017;16:279-286 pubmed 出版商 |
| Olokpa E, Bolden A, Stewart L. The Androgen Receptor Regulates PPAR? Expression and Activity in Human Prostate Cancer Cells. J Cell Physiol. 2016;231:2664-72 pubmed 出版商 |
| Khanna A, Rane J, Kivinummi K, Urbanucci A, Helenius M, Tolonen T, et al. CIP2A is a candidate therapeutic target in clinically challenging prostate cancer cell populations. Oncotarget. 2015;6:19661-70 pubmed |
| Elebro K, Butt S, Dorkhan M, Jernstrom H, Borgquist S. Age at first childbirth and oral contraceptive use are associated with risk of androgen receptor-negative breast cancer: the Malmö Diet and Cancer Cohort. Cancer Causes Control. 2014;25:945-57 pubmed 出版商 |
| Agaimy A, Lell M, Schaller T, Märkl B, Hornung J. 'Neuroendocrine' middle ear adenomas: consistent expression of the transcription factor ISL1 further supports their neuroendocrine derivation. Histopathology. 2015;66:182-91 pubmed 出版商 |
| Labbé D, Nowak D, Deblois G, Lessard L, Giguere V, Trotman L, et al. Prostate cancer genetic-susceptibility locus on chromosome 20q13 is amplified and coupled to androgen receptor-regulation in metastatic tumors. Mol Cancer Res. 2014;12:184-9 pubmed 出版商 |
| Lyu S, Yu Q, Ying G, Wang S, Wang Y, Zhang J, et al. Androgen receptor decreases CMYC and KRAS expression by upregulating let-7a expression in ER-, PR-, AR+ breast cancer. Int J Oncol. 2014;44:229-37 pubmed 出版商 |
| Rocha J, Zouanat F, Zoubeidi A, Hamel L, Benidir T, Scarlata E, et al. The Fer tyrosine kinase acts as a downstream interleukin-6 effector of androgen receptor activation in prostate cancer. Mol Cell Endocrinol. 2013;381:140-9 pubmed 出版商 |
| Lottrup G, Jørgensen A, Nielsen J, Jørgensen N, Duno M, Vinggaard A, et al. Identification of a novel androgen receptor mutation in a family with multiple components compatible with the testicular dysgenesis syndrome. J Clin Endocrinol Metab. 2013;98:2223-9 pubmed 出版商 |
| Hua S, Yao M, Vignarajan S, Witting P, Hejazi L, Gong Z, et al. Cytosolic phospholipase A2? sustains pAKT, pERK and AR levels in PTEN-null/mutated prostate cancer cells. Biochim Biophys Acta. 2013;1831:1146-57 pubmed 出版商 |
| Choucair K, Guérard K, Ejdelman J, Chevalier S, Yoshimoto M, Scarlata E, et al. The 16p13.3 (PDPK1) Genomic Gain in Prostate Cancer: A Potential Role in Disease Progression. Transl Oncol. 2012;5:453-60 pubmed |
| Ketola K, Kallioniemi O, Iljin K. Chemical biology drug sensitivity screen identifies sunitinib as synergistic agent with disulfiram in prostate cancer cells. PLoS ONE. 2012;7:e51470 pubmed 出版商 |
| Choucair K, Ejdelman J, Brimo F, Aprikian A, Chevalier S, Lapointe J. PTEN genomic deletion predicts prostate cancer recurrence and is associated with low AR expression and transcriptional activity. BMC Cancer. 2012;12:543 pubmed 出版商 |
| Park B, Park S, Koo J, Kim S, Park J, Cho J, et al. Homeodomain-interacting protein kinase 1 (HIPK1) expression in breast cancer tissues. Jpn J Clin Oncol. 2012;42:1138-45 pubmed 出版商 |
| McNamara K, Yoda T, Takagi K, Miki Y, Suzuki T, Sasano H. Androgen receptor in triple negative breast cancer. J Steroid Biochem Mol Biol. 2013;133:66-76 pubmed 出版商 |
| Chng K, Chang C, Tan S, Yang C, Hong S, Sng N, et al. A transcriptional repressor co-regulatory network governing androgen response in prostate cancers. EMBO J. 2012;31:2810-23 pubmed 出版商 |
| Lazarevic B, Hammarstrom C, Yang J, Ramberg H, Diep L, Karlsen S, et al. The effects of short-term genistein intervention on prostate biomarker expression in patients with localised prostate cancer before radical prostatectomy. Br J Nutr. 2012;108:2138-47 pubmed 出版商 |
| Lessard L, Labbé D, Deblois G, Begin L, Hardy S, Mes Masson A, et al. PTP1B is an androgen receptor-regulated phosphatase that promotes the progression of prostate cancer. Cancer Res. 2012;72:1529-37 pubmed 出版商 |
| Park S, Park H, Koo J, Yang W, Kim S, Park B. Higher expression of androgen receptor is a significant predictor for better endocrine-responsiveness in estrogen receptor-positive breast cancers. Breast Cancer Res Treat. 2012;133:311-20 pubmed 出版商 |
| Ketola K, Hilvo M, Hyötyläinen T, Vuoristo A, Ruskeepää A, Oresic M, et al. Salinomycin inhibits prostate cancer growth and migration via induction of oxidative stress. Br J Cancer. 2012;106:99-106 pubmed 出版商 |
| Morin A, Fritsch L, Mathieu J, Gilbert C, Guarmit B, Firlej V, et al. Identification of CAD as an androgen receptor interactant and an early marker of prostate tumor recurrence. FASEB J. 2012;26:460-7 pubmed 出版商 |
| Vainio P, Wolf M, Edgren H, He T, Kohonen P, Mpindi J, et al. Integrative genomic, transcriptomic, and RNAi analysis indicates a potential oncogenic role for FAM110B in castration-resistant prostate cancer. Prostate. 2012;72:789-802 pubmed 出版商 |
| Park S, Koo J, Kim M, Park H, Lee J, Kim S, et al. Androgen receptor expression is significantly associated with better outcomes in estrogen receptor-positive breast cancers. Ann Oncol. 2011;22:1755-62 pubmed 出版商 |
| Vainio P, Gupta S, Ketola K, Mirtti T, Mpindi J, Kohonen P, et al. Arachidonic acid pathway members PLA2G7, HPGD, EPHX2, and CYP4F8 identified as putative novel therapeutic targets in prostate cancer. Am J Pathol. 2011;178:525-36 pubmed 出版商 |
| Yu Q, Niu Y, Liu N, Zhang J, Liu T, Zhang R, et al. Expression of androgen receptor in breast cancer and its significance as a prognostic factor. Ann Oncol. 2011;22:1288-94 pubmed 出版商 |
| Claassen H, Schicht M, Brandt J, Reuse K, Schädlich R, Goldring M, et al. C-28/I2 and T/C-28a2 chondrocytes as well as human primary articular chondrocytes express sex hormone and insulin receptors--Useful cells in study of cartilage metabolism. Ann Anat. 2011;193:23-9 pubmed 出版商 |
| Moss P, Lyles B, Stewart L. The PPAR? ligand ciglitazone regulates androgen receptor activation differently in androgen-dependent versus androgen-independent human prostate cancer cells. Exp Cell Res. 2010;316:3478-88 pubmed 出版商 |
| Koo J, Jung W, Jeong J. Metastatic breast cancer shows different immunohistochemical phenotype according to metastatic site. Tumori. 2010;96:424-32 pubmed |
| Gannon P, Godin Ethier J, Hassler M, Delvoye N, Aversa M, Poisson A, et al. Androgen-regulated expression of arginase 1, arginase 2 and interleukin-8 in human prostate cancer. PLoS ONE. 2010;5:e12107 pubmed 出版商 |
| Chen H, Libertini S, George M, Dandekar S, Tepper C, Al Bataina B, et al. Genome-wide analysis of androgen receptor binding and gene regulation in two CWR22-derived prostate cancer cell lines. Endocr Relat Cancer. 2010;17:857-73 pubmed 出版商 |
| Nodin B, Zendehrokh N, Brändstedt J, Nilsson E, Manjer J, Brennan D, et al. Increased androgen receptor expression in serous carcinoma of the ovary is associated with an improved survival. J Ovarian Res. 2010;3:14 pubmed 出版商 |
| Singh J, Xie C, Yao M, Hua S, Vignarajan S, Jardine G, et al. Food extracts consumed in Mediterranean countries and East Asia reduce protein concentrations of androgen receptor, phospho-protein kinase B, and phospho-cytosolic phospholipase A(2)alpha in human prostate cancer cells. J Nutr. 2010;140:786-91 pubmed 出版商 |
| Chen H, Libertini S, Wang Y, Kung H, Ghosh P, Mudryj M. ERK regulates calpain 2-induced androgen receptor proteolysis in CWR22 relapsed prostate tumor cell lines. J Biol Chem. 2010;285:2368-74 pubmed 出版商 |
| Waltering K, Helenius M, Sahu B, Manni V, Linja M, Janne O, et al. Increased expression of androgen receptor sensitizes prostate cancer cells to low levels of androgens. Cancer Res. 2009;69:8141-9 pubmed 出版商 |
| Iljin K, Ketola K, Vainio P, Halonen P, Kohonen P, Fey V, et al. High-throughput cell-based screening of 4910 known drugs and drug-like small molecules identifies disulfiram as an inhibitor of prostate cancer cell growth. Clin Cancer Res. 2009;15:6070-8 pubmed 出版商 |
| Yao M, Taylor R, Richards M, Sved P, Wong J, Eisinger D, et al. Prostate-regenerating capacity of cultured human adult prostate epithelial cells. Cells Tissues Organs. 2010;191:203-12 pubmed 出版商 |
| Vellaichamy A, Sreekumar A, Strahler J, Rajendiran T, Yu J, Varambally S, et al. Proteomic interrogation of androgen action in prostate cancer cells reveals roles of aminoacyl tRNA synthetases. PLoS ONE. 2009;4:e7075 pubmed 出版商 |
| Chen S, Kesler C, Paschal B, Balk S. Androgen receptor phosphorylation and activity are regulated by an association with protein phosphatase 1. J Biol Chem. 2009;284:25576-84 pubmed 出版商 |
| Péant B, Diallo J, Dufour F, Le Page C, Delvoye N, Saad F, et al. Over-expression of IkappaB-kinase-epsilon (IKKepsilon/IKKi) induces secretion of inflammatory cytokines in prostate cancer cell lines. Prostate. 2009;69:706-18 pubmed 出版商 |
| Bjorkman M, Iljin K, Halonen P, Sara H, Kaivanto E, Nees M, et al. Defining the molecular action of HDAC inhibitors and synergism with androgen deprivation in ERG-positive prostate cancer. Int J Cancer. 2008;123:2774-81 pubmed 出版商 |
| Urbanucci A, Waltering K, Suikki H, Helenius M, Visakorpi T. Androgen regulation of the androgen receptor coregulators. BMC Cancer. 2008;8:219 pubmed 出版商 |
| Wu Y, Li H, Lv X, Wei Q, Li X, Liu X, et al. Overexpression of JKTBP1 induces androgen-independent LNCaP cell proliferation through activation of epidermal growth factor-receptor (EGF-R). Cell Biochem Funct. 2008;26:467-77 pubmed 出版商 |
| Diallo J, Aldejmah A, Mouhim A, Fahmy M, Koumakpayi I, Sircar K, et al. Co-assessment of cytoplasmic and nuclear androgen receptor location in prostate specimens: potential implications for prostate cancer development and prognosis. BJU Int. 2008;101:1302-9 pubmed 出版商 |
| Ponti G, Losi L, Pellacani G, Rossi G, Presutti L, Mattioli F, et al. Wnt pathway, angiogenetic and hormonal markers in sporadic and familial adenomatous polyposis-associated juvenile nasopharyngeal angiofibromas (JNA). Appl Immunohistochem Mol Morphol. 2008;16:173-8 pubmed 出版商 |
| Ariazi E, Leitao A, Oprea T, Chen B, Louis T, Bertucci A, et al. Exemestane's 17-hydroxylated metabolite exerts biological effects as an androgen. Mol Cancer Ther. 2007;6:2817-27 pubmed |
| Compagno D, Merle C, Morin A, Gilbert C, Mathieu J, Bozec A, et al. SIRNA-directed in vivo silencing of androgen receptor inhibits the growth of castration-resistant prostate carcinomas. PLoS ONE. 2007;2:e1006 pubmed |
| Libertini S, Tepper C, Rodriguez V, Asmuth D, Kung H, Mudryj M. Evidence for calpain-mediated androgen receptor cleavage as a mechanism for androgen independence. Cancer Res. 2007;67:9001-5 pubmed |
| Araki S, Omori Y, Lyn D, Singh R, Meinbach D, Sandman Y, et al. Interleukin-8 is a molecular determinant of androgen independence and progression in prostate cancer. Cancer Res. 2007;67:6854-62 pubmed |
| Wang W, Bergh A, Damber J. Increased expression of CCAAT/enhancer-binding protein beta in proliferative inflammatory atrophy of the prostate: relation with the expression of COX-2, the androgen receptor, and presence of focal chronic inflammation. Prostate. 2007;67:1238-46 pubmed |
| Konduri S, Schwarz M, Cafasso D, Schwarz R. Androgen receptor blockade in experimental combination therapy of pancreatic cancer. J Surg Res. 2007;142:378-86 pubmed |
| Cordon Cardo C, Kotsianti A, Verbel D, Teverovskiy M, Capodieci P, Hamann S, et al. Improved prediction of prostate cancer recurrence through systems pathology. J Clin Invest. 2007;117:1876-83 pubmed |
| Tepper C, Vinall R, Wee C, Xue L, Shi X, Burich R, et al. GCP-mediated growth inhibition and apoptosis of prostate cancer cells via androgen receptor-dependent and -independent mechanisms. Prostate. 2007;67:521-35 pubmed |
| Ejskjaer K, Sørensen B, Poulsen S, Forman A, Nexø E, Mogensen O. Expression of the epidermal growth factor system in endometrioid endometrial cancer. Gynecol Oncol. 2007;104:158-67 pubmed |
| Havens A, Jung Y, Sun Y, Wang J, Shah R, Buhring H, et al. The role of sialomucin CD164 (MGC-24v or endolyn) in prostate cancer metastasis. BMC Cancer. 2006;6:195 pubmed |
| Tanyel F, Yüzbaşioğlu A, Kocaefe C, Orhan D, Ozguc M. Androgen receptor immunostaining and androgen receptor messenger ribonucleic acid expression are increased in cremaster muscles associated with undescended testis. Urology. 2006;67:855-8 pubmed |
| Theodoropoulos V, Tsigka A, Mihalopoulou A, Tsoukala V, Lazaris A, Patsouris E, et al. Evaluation of neuroendocrine staining and androgen receptor expression in incidental prostatic adenocarcinoma: prognostic implications. Urology. 2005;66:897-902 pubmed |
- 免疫组化-石蜡切片; 人类; 1:100
- 免疫组化; 人类; 1:100
| Asioli S, Marucci G, Ficarra G, Stephens M, Foschini M, Ellis I, et al. Polymorphous adenocarcinoma of the breast. Report of three cases. Virchows Arch. 2006;448:29-34 pubmed |
| Ejskjaer K, Sørensen B, Poulsen S, Mogensen O, Forman A, Nexø E. Expression of the epidermal growth factor system in human endometrium during the menstrual cycle. Mol Hum Reprod. 2005;11:543-51 pubmed |
- 免疫组化; 人类; 1:80
- 免疫印迹; 人类; 1:200
| Sonneveld E, Jansen H, Riteco J, Brouwer A, van der Burg B. Development of androgen- and estrogen-responsive bioassays, members of a panel of human cell line-based highly selective steroid-responsive bioassays. Toxicol Sci. 2005;83:136-48 pubmed |
| Brodzki A, Łopuszyński W, Millan Y, Tatara M, Brodzki P, Kulpa K, et al. Androgen and Estrogen Receptor Expression in Different Types of Perianal Gland Tumors in Male Dogs. Animals (Basel). 2021;11: pubmed 出版商 |
| Liu W, Wang C, Wang S, Zeng K, Wei S, Sun N, et al. PRPF6 promotes androgen receptor/androgen receptor-variant 7 actions in castration-resistant prostate cancer cells. Int J Biol Sci. 2021;17:188-203 pubmed 出版商 |
| Bahnassy S, Thangavel H, Quttina M, Khan A, Dhanyalayam D, Ritho J, et al. Constitutively active androgen receptor supports the metastatic phenotype of endocrine-resistant hormone receptor-positive breast cancer. Cell Commun Signal. 2020;18:154 pubmed 出版商 |
| Govindan S, Siraganahalli Eswaraiah M, Basavaraj C, Adinarayan M, Sankaran S, Bakre M. Androgen Receptor mRNA levels determine the prognosis in triple-negative breast cancer patients. BMC Cancer. 2020;20:745 pubmed 出版商 |
| Song H, Sun N, Lin L, Wei S, Zeng K, Liu W, et al. Splicing factor PRPF6 upregulates oncogenic androgen receptor signaling pathway in hepatocellular carcinoma. Cancer Sci. 2020;111:3665-3678 pubmed 出版商 |
| Ludwik K, Sandusky Z, Stauffer K, Li Y, Boyd K, O Doherty G, et al. RSK2 Maintains Adult Estrogen Homeostasis by Inhibiting ERK1/2-Mediated Degradation of Estrogen Receptor Alpha. Cell Rep. 2020;32:107931 pubmed 出版商 |
| Begemann D, Wang Y, Yang W, Kyprianou N. Androgens modify therapeutic response to cabazitaxel in models of advanced prostate cancer. Prostate. 2020;80:926-937 pubmed 出版商 |
| Fletcher C, Sulpice E, Combe S, Shibakawa A, Leach D, Hamilton M, et al. Androgen receptor-modulatory microRNAs provide insight into therapy resistance and therapeutic targets in advanced prostate cancer. Oncogene. 2019;: pubmed 出版商 |
| Mounir Z, Korn J, Westerling T, Lin F, Kirby C, Schirle M, et al. ERG signaling in prostate cancer is driven through PRMT5-dependent methylation of the Androgen Receptor. elife. 2016;5: pubmed 出版商 |
| Shah R, Mehra R, Chinnaiyan A, Shen R, Ghosh D, Zhou M, et al. Androgen-independent prostate cancer is a heterogeneous group of diseases: lessons from a rapid autopsy program. Cancer Res. 2004;64:9209-16 pubmed |
| Das D, Shah R, Imperiale M. Detection and expression of human BK virus sequences in neoplastic prostate tissues. Oncogene. 2004;23:7031-46 pubmed |
| Nabi G, Seth A, Dinda A, Gupta N. Computer based receptogram approach: an objective way of assessing immunohistochemistry of androgen receptor staining and its correlation with hormonal response in metastatic carcinoma of prostate. J Clin Pathol. 2004;57:146-50 pubmed |
| Tepper C, Boucher D, Ryan P, Ma A, Xia L, Lee L, et al. Characterization of a novel androgen receptor mutation in a relapsed CWR22 prostate cancer xenograft and cell line. Cancer Res. 2002;62:6606-14 pubmed |
| Shi X, Ma A, Xia L, Kung H, de Vere White R. Functional analysis of 44 mutant androgen receptors from human prostate cancer. Cancer Res. 2002;62:1496-502 pubmed |
